author-photo

Arijit Chakravarty

Takeda Pharmaceutical Company
Millennium Pharmaceuticals

95

Papers

1059

Citations

Citation Trend

Filter By

Papers (95) Sort By

Journal Conference Others

Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (0)
Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection

2021
Show All
- Source
- Cite
- Save
Citations (0)
Individually Optimal Choices can be Collectively Disastrous in COVID-19 Disease Control

2021
Show All
- Source
- Cite
- Save
Citations (0)
Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (0)
Beyond the new normal: assessing the feasibility of vaccine-based elimination of SARS-CoV-2

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (12)
Controlling long-term SARS-CoV-2 infections is important for slowing viral evolution

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (2)
Detecting in-school transmission of SARS-CoV-2 from case ratios and documented clusters

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
The specter of Manaus: the risks of a rapid return to pre-pandemic conditions after COVID-19 vaccine rollout

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)